Alternative access in high-risk patients in the era of transfemoral aortic valve replacement.
Alina ZubarevichMarcin SzczechowiczRolf-Alexander JánosiAlexander LindTienush RassafRizwan MalikMatthias ThielmannBastian SchmackMarkus KamlerArjang RuhparwarAlexander WeymannDaniel WendtPublished in: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (2021)
Transapical and transaortic TAVR in high-risk patients unsuitable for transfemoral access is still a reasonable alternative in these patients. STS and STS/ACC-score appear to be highly accurate in predicting in-hospital mortality in high-risk patients undergoing TAVR.
Keyphrases
- aortic valve replacement
- ejection fraction
- end stage renal disease
- transcatheter aortic valve replacement
- aortic stenosis
- newly diagnosed
- transcatheter aortic valve implantation
- patients undergoing
- aortic valve
- chronic kidney disease
- prognostic factors
- high resolution
- coronary artery disease
- mitral valve
- patient reported
- atrial fibrillation